Verilogue is now part of Insagic, a Publicis Health company, is a groundbreaking insights and advisory business that combines data, design, and dialogues to deliver activatable insights and transformational intelligence that our clients need to succeed and grow in today’s platform world. Read the MM+M Game Changers 2023 profile here.
Philadelphia, PA., February 8, 2023—Insagic, a next-generation insights and advisory business that combines data, design, and dialogues, announced today that its Manager, Linguistic Insights & Analytics Zach Hebert has been named an honoree to the GreenBook Future List 2023. “We are extremely proud of Zach’s achievements as a teammate, leader, and client advocate,” said Insagic…
June is Alzheimer’s & Brain Awareness Month, dedicated to raising awareness for the more than 55 million people worldwide who are living with Alzheimer’s or another dementia. Verilogue’s RevealMR portal provides access to the largest healthcare dialogue database, enabling endless unique insights for our clients and researchers. Our 2022 Alzheimer’s Disease infographic, constructed from the…
June is Migraine & Headache Awareness Month, a time to champion advocacy and research, build community, and raise awareness for the 3.3 million people in the US (and those around the world) who are living with chronic migraine. For an example of our extensive experience in migraine studies, read this one-page success story to learn…
Click here to download the presentation Across the US, patients of color have a lower rate of flu vaccination than white patients. These disparities are consistent regardless of the overall flu vaccination rate, and with increased attention on the impact of health disparities due to COVID, multiple explanations are proposed for lower vaccination rates among…
Lu, E., Solovyeva, K., Hebert, Z., Kietzer, L., Griffiths, S., Eid Antoun, Z., Keeley, T., & Alfonso-Cristancho, R., (2021, September 5-8). Shared decision making in severe asthma therapy: Qualitative study of physician-patient communication [Poster]. European Respiratory Society (ERS) International Congress. Patient engagement in biologic treatment of severe asthma becomes a driving force after first starting…
COVID-19 has radically changed healthcare. Some of these changes are temporary workarounds. Some are here to stay. And some already were in place, with COVID accelerating the changes. All of the changes have had an impact on patient behavior: how they approach their conditions; talk about their conditions; and make decisions around their conditions. We…
Whitepaper When the COVID-19 pandemic began in early 2020, there was widespread concern about how fast an effective vaccine could be developed – if one could be developed at all. As we move into Spring 2021 with multiple authorized vaccines on hand, the conversation has changed: the challenge expressed by public health experts is not…
Whitepaper In the exam room, discussion of risks associated with COVID-19 are evolving as we learn more about the underlying characteristics of the virus and disease. Through the analysis of exam room conversations with specific discussion of COVID-19, Verilogue compared HCP-PT conversations collected early in the pandemic against more recent conversations, exploring how discussions of…
In the exam room, discussion of COVID-19-related risks are evolving as we learn more about the underlying characteristics of this virus and disease. Through the analysis of >1,400 exam room conversations with specific discussion of COVID-19, our research team has identified tactics that physicians are using to educate patients on personal states of risk (e.g.…